An Unusual Presentation of Desmoid Tumor in the Ileum

Neeraj Singh; Sharma, Rohit; Dorman, Sanford A.; Dy, Victor C.
September 2006
American Surgeon;Sep2006, Vol. 72 Issue 9, p821
Academic Journal
Desmoid tumors are nonencapsulated, locally invasive tumors of fibrous origin. Although lacking the ability to metastasize, they are notorious for recurrence. A wide variety of locations have been documented in the literature with respect to the origin of these tumors, intra-abdominal desmoids are commonly found in the mesentery. We present the report of a case in which a sporadic desmoid tumor originated from the wall of the ileum. The patient was successfully treated with surgery alone, and has remained recurrence free on follow-up. Modalities of treatment documented in the literature include surgery, nonsteroidal, anti-inflammatory drugs such as sulindac, and chemotherapeutic drugs such as vinblastine and methotrexate, radiotherapy, and, recently, tyrosine kinase inhibitors such as Imatinib (gleevec). Of all the options described, surgery with tumor-free margins has been defined as the best treatment modality.


Related Articles

  • How I do it: surgical management of gastrointestinal stromal tumors. Raut, Chandrajit P.; Ashley, Stanley W. // Journal of Gastrointestinal Surgery;Sep2008, Vol. 12 Issue 9, p1592 

    The surgical management of gastrointestinal stromal tumors (GISTs) has been impacted by the development of tyrosine kinase inhibitors (TKIs), advances in surgical technique, and a better understanding of the natural history of this unique disease. In this article, we review the technical aspects...

  • Leczenie chirurgiczne nowotworów podÅ›cieliskowych przewodu pokarmowego (GIST). Ruka, Włodzimierz; Rutkowski, Piotr; Zdzienicki, Marcin; Nowecki, Zbigniew I. // Gastroenterologia Polska / Gastroenterology;2009, Vol. 16 Issue 2, p129 

    Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of gastrointestinal tract. The activating mutation of KIT or PDGFRA genes is initial step in their carcinogenesis process; over expression of KIT receptor, as a consequence of mutation of protooncogene KIT, is highly...

  • Imatinib (STI-571) heals a gastrocutaneous fistula resulting from a malignant gastric stromal tumor. Ng, Enders K.W.; Wong, Simon K.H.; Mok, Tony S.K.; Chan, W.Y.; Chung, S.C. Sydney // Gastric Cancer;Jun2003, Vol. 6 Issue 2, p122 

    The management of inoperable giant malignant gastrointestinal stromal tumor (GIST) of the stomach used to be a formidable task. We report our success with the use of STI-571 in treating a patient with huge GIST of the stomach complicated by gastrocutaneous fistula after an unsuccessful...

  • Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib. Wicherts, Dennis A.; van Coevorden, Frits; Klomp, Houke M.; van Huizum, Martine A.; Kerst, J. Martijn; Haas, Rick L. M.; van Boven, Hester H.; van der Hage, J. A. // World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, p1 

    Curative surgical treatment of recurrent, locally advanced dermatofibrosarcoma protuberans is often limited owing to a close relation of the tumor with important anatomical structures. Targeted therapy with imatinib, a tyrosine kinase inhibitor, may cause significant reduction of tumor volume,...

  • Response to Reader's Queries. Dudeja, Vikas; Gupta, Panjak; Al-Refaie, Waddah // Journal of Gastrointestinal Surgery;Dec2010, Vol. 14 Issue 12, p2020 

    No abstract available.

  • Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry. Sato, Shinsuke; Tsujinaka, Toshimasa; Masuzawa, Toru; Yamamoto, Kazuyoshi; Takahashi, Tsuyoshi; Yamashita, Yoshito; Fujita, Junya; Takagi, Masakazu; Hirota, Seiichi; Nishida, Toshirou // Surgery Today;Jan2017, Vol. 47 Issue 1, p58 

    Purpose: To define the role of surgery for metastatic/recurrent lesions after resection of primary gastrointestinal stromal tumors (GISTs). Methods: Based on data obtained from the Kinki GIST registry, patients with recurrence or metastasis were divided into a surgical treatment group (ST...

  • Novel small-molecule inhibitor shows promise for pigmented villonodular synovitis. Adams, Stacey; Southall, Jennifer; Todak, Alexandra // Hem/Onc Today;6/25/2014, Vol. 15 Issue 12, p17 

    The article discusses the results of a study revealing the inducement effect of the novel oral tyrosine kinase inhibitor PLX3397 on tumor shrinkage and stable disease in patients with recurrent pigmented villonodular synovitis (PVNS), a rare proliferative neoplasm causing tumors in joint...

  • Inflammatory myofibroblastic tumor of the mesentery: a clinical dilemma. Shatzel, Joseph; Wooten, Kimberly; Ankola, Anita; Cheney, Richard; Morrison, Carl; Skitzki, Joseph // International Journal of Clinical Oncology;Aug2012, Vol. 17 Issue 4, p380 

    Although rare, extra-pulmonary inflammatory myofibroblastic tumors (IMTs) are becoming increasingly recognized. While surgical resection is currently an effective and accepted treatment for IMTs, the optimal management of unresectable or residual IMTs remains a clinical dilemma. We present the...

  • The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases. Ozanne, James; Prescott, Alan R.; Clark, Kristopher // Biochemical Journal;1/15/2015, Vol. 465 Issue 2, p271 

    Macrophages switch to an anti-inflammatory, 'regulatory'-like phenotype characterized by the production of high levels of interleukin (IL)-10 and low levels of pro-inflammatory cytokines to promote the resolution of inflammation. A potential therapeutic strategy for the treatment of chronic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics